Sonali Kumar
Delhi, DL 110007, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Methodological approach to investigate peroxiredoxin 1 deacetylation by histone deacetylase 6.
Journal: Methods in enzymology
Published: September 03, 2026
Kisspeptin System: A Modulator of Neuroinflammation and Behaviour in Temporal Lobe Epileptic Rats.
Journal: Molecular neurobiology
Published: October 25, 2025
Pyk2 dysregulation in temporal lobe epilepsy: insights from human resected tissues and pharmacological modulation in a rodent model.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: July 06, 2025
HDAC6 inhibition enhances peroxiredoxin 1 acetylation to mitigate oxidative stress and seizure activity in focal cortical dysplasia.
Journal: Experimental neurology
Published: January 15, 2025
Role of non-receptor tyrosine kinases in epilepsy: significance and potential as therapeutic targets.
Journal: Expert opinion on therapeutic targets
Published: April 17, 2024
Epigenetics in epilepsy.
Journal: Progress in molecular biology and translational science
Published: May 24, 2023
Epigenetics of neurological diseases.
Journal: Progress in molecular biology and translational science
Published: May 24, 2023
Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets.
Journal: Expert opinion on therapeutic targets
Published: July 07, 2021
Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy.
Journal: Expert opinion on therapeutic targets
Published: December 04, 2020
IDH1-R132H-FAT1-ROS-HIF-1α Signaling Pathway Inhibits Glioblastoma Tumor Progression.
Journal: Neurology India
Published: October 28, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026